{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:08:31Z","timestamp":1794953311720,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Following surgery for soft tissue sarcoma of the retroperitoneum, the predominant pattern of failure is local recurrence, which remains the main cause of death. Radiotherapy is utilized to reduce recurrence rates but the efficacy of this strategy has not been definitely established. As treatment tolerability is more favorable with preoperative radiotherapy, normofractionated neoadjuvant treatment is the current approach. The final results of the prospective, randomized STRASS (EORTC 62092) trial, which compared the efficacy of this combined treatment to that of surgery alone, are still awaited; preliminary results presented at the 2019 ASCO Annual Meeting indicated that combined treatment is associated with better local control in patients with liposarcoma (74.5% of the cohort, 11% benefit in abdominal progression free survival\u00a0after 3\u2009years, <jats:italic>p<\/jats:italic>\u2009=\u20090.049). Particles allow better sparing of surrounding tissues at risk, e.g., bowel epithelium, and carbon ions additionally offer biologic advantages and are preferred in slow growing tumors. Furthermore, hypofractionation allows for a significantly shorter treatment interval with a lower risk of progression during radiotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods and design<\/jats:title>\n                <jats:p>We present a prospective, randomized, monocentric phase II trial. Patients with resectable or marginally resectable, histologically confirmed soft tissue sarcoma of the retroperitoneum will be randomized between neoadjuvant proton or neoadjuvant carbon ion radiotherapy in active scanning beam application technique (39\u2009Gy [relative biological effectiveness, RBE] in 13 fractions [5\u20136 fractions per week] in each arm). The primary objective is the safety and feasibility based on the proportion of grade 3\u20135 toxicity (CTCAE, version 5.0) in the first 12\u2009months after surgery or discontinuation of treatment for any reason related to the treatment. Local control, local progression-free survival, disease-free survival, overall survival, and quality of life are the secondary endpoints of the study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The aim of this study is to confirm that hypofractionated, accelerated preoperative radiotherapy is safe and feasible. The rationale for the use of particle therapy is the potential for reduced toxicity. The data will lay the groundwork for a randomized phase III trial comparing hypofractionated proton and carbon ion irradiation with regard to local control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04219202\">NCT04219202<\/jats:ext-link>. Retrospectively registered on January 6, 2020<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05069-z","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:00:14Z","timestamp":1613152814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-6426","authenticated-orcid":false,"given":"K.","family":"Seidensaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hommertgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jaekel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. B.","family":"Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mechtesheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nienhueser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"issue":"7","key":"5069_CR1","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/S1470-2045(16)30050-X","volume":"17","author":"DP Nussbaum","year":"2016","unstructured":"Nussbaum DP, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. 2016;17(7):966\u201375.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5069_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"5069_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/SLA.0000000000001149","volume":"263","author":"MCB Tan","year":"2016","unstructured":"Tan MCB, et al. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg. 2016;263(3):593\u2013600.","journal-title":"Ann Surg"},{"issue":"3","key":"5069_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","volume":"228","author":"JJ Lewis","year":"1998","unstructured":"Lewis JJ, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355\u201365.","journal-title":"Ann Surg"},{"issue":"9","key":"5069_CR5","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/1097-0142(19810501)47:9<2147::AID-CNCR2820470907>3.0.CO;2-Z","volume":"47","author":"HS Cody Iii","year":"1981","unstructured":"Cody Iii HS, et al. The continuing challenge of retroperitoneal sarcomas. Cancer. 1981;47(9):2147\u201352.","journal-title":"Cancer"},{"issue":"3","key":"5069_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.sla.0000086542.11899.38","volume":"238","author":"S Singer","year":"2003","unstructured":"Singer S, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238(3):358\u201370 discussion 370-1.","journal-title":"Ann Surg"},{"issue":"7","key":"5069_CR7","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/cncr.21761","volume":"106","author":"GA Porter","year":"2006","unstructured":"Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006;106(7):1610\u20136.","journal-title":"Cancer"},{"issue":"6","key":"5069_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PPO.0000000000000078","volume":"20","author":"M Uhl","year":"2014","unstructured":"Uhl M, Herfarth K, Debus J. Comparing the use of protons and carbon ions for treatment. Cancer J. 2014;20(6):433\u20139.","journal-title":"Cancer J"},{"issue":"4","key":"5069_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/PPO.0b013e3181b01935","volume":"15","author":"U Weber","year":"2009","unstructured":"Weber U, Kraft G. Comparison of carbon ions versus protons. Cancer J. 2009;15(4):325\u201332.","journal-title":"Cancer J"},{"issue":"1","key":"5069_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.adro.2016.12.003","volume":"2","author":"TF DeLaney","year":"2017","unstructured":"DeLaney TF, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017;2(1):85\u201393.","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"5069_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0168-9002(93)91335-K","volume":"330","author":"T Haberer","year":"1993","unstructured":"Haberer T, et al. Magnetic scanning system for heavy ion therapy. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 1993;330(1):296\u2013305.","journal-title":"Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment"},{"issue":"7","key":"5069_CR12","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3109\/0284186X.2010.498432","volume":"49","author":"SE Combs","year":"2010","unstructured":"Combs SE, et al. Heidelberg ion therapy center (HIT): initial clinical experience in the first 80 patients. Acta Oncol. 2010;49(7):1132\u201340.","journal-title":"Acta Oncol"},{"issue":"2","key":"5069_CR13","first-page":"119","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull BA. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. Am Stat. 1998;52(2):119\u201326.","journal-title":"Am Stat"},{"key":"5069_CR14","doi-asserted-by":"publisher","DOI":"10.1201\/b11826","volume-title":"Flexible imputation of missing data","author":"S van Buuren","year":"2012","unstructured":"van Buuren, S., Flexible imputation of missing data. Chapman & Hall\/CRC, 2012."},{"issue":"3","key":"5069_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1740774508091600","volume":"5","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, White IR, Wood AM. Imputation methods for missing outcome data in meta-analysis of clinical trials. Clin Trials. 2008;5(3):225\u201339.","journal-title":"Clin Trials"},{"issue":"1","key":"5069_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5069_CR17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/annonc\/mds516","volume":"24","author":"C Le P\u00e9choux","year":"2013","unstructured":"Le P\u00e9choux C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol. 2013;24(3):832\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"5069_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/SLA.0000000000001063","volume":"262","author":"KJ Kelly","year":"2015","unstructured":"Kelly KJ, et al. Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study. Ann Surg. 2015;262(1):156\u201362.","journal-title":"Ann Surg"},{"issue":"1","key":"5069_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","volume":"27","author":"A Gronchi","year":"2009","unstructured":"Gronchi A, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27(1):24\u201330.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5069_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/annonc\/mdr323","volume":"23","author":"A Gronchi","year":"2012","unstructured":"Gronchi A, et al. Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol. 2012;23(4):1067\u201373.","journal-title":"Ann Oncol"},{"key":"5069_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/1471-2407-14-617","volume":"14","author":"F Roeder","year":"2014","unstructured":"Roeder F, et al. Clinical phase I\/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis. BMC Cancer. 2014;14:617.","journal-title":"BMC Cancer"},{"issue":"3","key":"5069_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clon.2010.01.005","volume":"22","author":"T Guerrero Urbano","year":"2010","unstructured":"Guerrero Urbano T, et al. Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol (R Coll Radiol). 2010;22(3):236\u201344.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"5069_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ijrobp.2013.11.214","volume":"88","author":"S Chopra","year":"2014","unstructured":"Chopra S, et al. Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study. Int J Radiat Oncol Biol Phys. 2014;88(3):630\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5069_CR24","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.ijrobp.2011.10.014","volume":"83","author":"EL Swanson","year":"2012","unstructured":"Swanson EL, et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys. 2012;83(5):1549\u201357.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"5069_CR25","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","volume":"40","author":"H Kose\u0142a-Paterczyk","year":"2014","unstructured":"Kose\u0142a-Paterczyk H, et al. Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas. Eur J Surg Oncol. 2014;40(12):1641\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"5069_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","volume":"41","author":"JD Pennington","year":"2018","unstructured":"Pennington JD, et al. Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas. Am J Clin Oncol. 2018;41(12):1154\u201361.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"5069_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","volume":"13","author":"CM van Leeuwen","year":"2018","unstructured":"van Leeuwen CM, et al. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. 2018;13(1):96.","journal-title":"Radiat Oncol"},{"issue":"4","key":"5069_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ijrobp.2008.12.019","volume":"75","author":"I Serizawa","year":"2009","unstructured":"Serizawa I, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Physics. 2009;75(4):1105\u201310.","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"15_suppl","key":"5069_CR29","doi-asserted-by":"publisher","first-page":"11001","DOI":"10.1200\/JCO.2019.37.15_suppl.11001","volume":"37","author":"S Bonvalot","year":"2019","unstructured":"Bonvalot S, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. J Clin Oncol. 2019;37(15_suppl):11001.","journal-title":"J Clin Oncol"},{"issue":"10","key":"5069_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","volume":"21","author":"S Bonvalot","year":"2020","unstructured":"Bonvalot S, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1366\u201377.","journal-title":"Lancet Oncol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-021-05069-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05069-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T18:03:49Z","timestamp":1613153029000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05069-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5069"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05069-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol, patient information, and consent are approved by the ethics committee of the University of Heidelberg (S-389\/2018). Furthermore, the trial is approved by the German Federal Office for Radiation Protection (Bundesamt fuer Strahlenschutz) (Z5-22461\/2-2018-009). Written informed consent will be obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}